Clinical

Dataset Information

0

BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer


ABSTRACT: The BESPOKE CRC study will prospectively enroll patients who have undergone surgery for stage I to IV colorectal cancer (CRC) and who have residual formalin-fixed paraffin-embedded (FFPE) tissue available will provide FFPE and whole blood samples. Patients will receive SIGNATERA test results and may be recommended for post-operative systemic therapy or observation by their treating clinician. Patients will be followed for up to two years with periodic whole blood collection. The study also has a control arm that will consist of matched Stage I to IV CRC cases that have a minimum of least 2 years clinical follow-up data.

DISEASE(S): Colon Cancer,Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2329735 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2022-02-07 | GSE192667 | GEO
2021-11-04 | GSE106584 | GEO
2014-02-13 | GSE54004 | GEO
2012-10-02 | E-GEOD-32651 | biostudies-arrayexpress
2016-11-30 | GSE88808 | GEO
2016-11-30 | GSE90463 | GEO
2016-11-30 | GSE89193 | GEO
2014-02-13 | E-GEOD-54004 | biostudies-arrayexpress
2010-01-13 | GSE18769 | GEO
2010-01-13 | GSE18767 | GEO